Clinical Trials Directory

Trials / Unknown

UnknownNCT05454163

Post-radiotherapy Rhinosinusitis in Children

Evaluation of Chronic Rhinosinusitis in Children Managed for Cervicofacial Mesenchymal Malignancy

Status
Unknown
Phase
Study type
Observational
Enrollment
55 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Chronic rhinosinusitis (CRS) is a frequent complication of facial cancer treatment, mainly related to radiotherapy. However, while radiological involvement is frequent, clinical expression seems less important. Few studies have investigated the incidence of this condition in the pediatric population while its evolution seems to be very chronic even if a partial improvement may occur with time. Our objective is therefore to study the impact of CSR in children treated for cancer of the cervicofacial region, to evaluate its incidence and medium-term evolution in order to determine whether it is necessary to set up a specific follow-up in these patients. The clinical impact of CSR is assessed by a specific SNOT 22 questionnaire in children treated for a head-neck mesenchymal malignancy in comparison with a control population consisting of children treated for a mesenchymal malignancy of non-head-neck location.

Conditions

Interventions

TypeNameDescription
OTHERSNOT 22 questionnaire22 items, score between 0 and 5; sum, minimum = 0, maximum = 110; higher score = higher impact on quality of life)

Timeline

Start date
2022-10-01
Primary completion
2025-10-01
Completion
2025-10-01
First posted
2022-07-12
Last updated
2022-07-12

Source: ClinicalTrials.gov record NCT05454163. Inclusion in this directory is not an endorsement.

Post-radiotherapy Rhinosinusitis in Children (NCT05454163) · Clinical Trials Directory